Episode Details

Back to Episodes
QuidelOrtho's Q1: Milder Flu, China Disruptions

QuidelOrtho's Q1: Milder Flu, China Disruptions

Published 2 days, 2 hours ago
Description

QuidelOrthos Q1 performance was disappointing, with revenue missing estimates by 7% and earnings per share coming in at -$0.04 against expectations of $0.36. EBITDA also fell short of forecasts. The company attributed the poor results to a milder flu season and delays in China and the Middle East. Full-year revenue guidance was lowered to $2.73 billion from $2.8 billion, and adjusted EPS midpoint was reduced by 14%. Operating margins flipped negative at -5.1% from positive 4.7% last year. Analysts questioned the companys performance, particularly in China, where disruptions cost about $30 million. The company outlined plans for a margin rebound in the second half through stabilizing China orders, core business gains, and new products. Cost cuts and factory consolidations are also in the works.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/e95dcb539ceb9864

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us